CompletedNCT03345342
This study exists to explore whether the medication Paliperidone could improve care and understanding. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 70 Years
- Countries
- Argentina, Australia, Brazil, Bulgaria, Czech Republic, France, China, Hungary, India, Italy, Malaysia, Mexico, Poland, Russian Federation, South Africa, South Korea, Spain, Taiwan, Turkey, Ukraine, United States
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT01051531
This study exists to better understand the safety of the medication Paliperidone and how manageable it feels in practice. Researchers are trying to understand whether the medication Paliperidone can better prevent setbacks and support longer-term stability.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, China, Malaysia, New Zealand, Philippines, South Korea, Taiwan, Thailand
- Sponsor
- Janssen Research & Development, LLC
- Condition
- Schizophrenia
CompletedNCT01481883
This study exists to compare options and see whether this type of care offers something meaningfully different. Researchers are trying to understand whether this type of care can improve attention, thinking, or day-to-day functioning.
SchizophreniaOtherFrom 18 Years to 45 Years
- Countries
- Australia
- Sponsor
- The Alfred
- Condition
- Schizophrenia
CompletedNCT03859973
This study exists to compare options and see whether a medication treatment offers something meaningfully different. Researchers are trying to understand what a medication treatment can reveal about signals in the brain or body that may guide care later on.
SchizophreniaOtherFrom 18 Years to 50 Years
- Countries
- Australia, Canada, France, New Zealand, United Kingdom, United States
- Sponsor
- Boehringer Ingelheim
- Condition
- Schizophrenia
CompletedNCT05253417
This study exists to compare options and see whether a digital app or remote support tool offers something meaningfully different. Researchers are trying to understand whether a digital app or remote support tool can improve sleep, daily rhythms, and longer-term stability.
AnxietyOtherFrom 18 Years to 65 Years
- Countries
- Australia
- Sponsor
- Bod Australia
- Condition
- Anxiety
TerminatedNCT02827513
This study exists to better understand the safety of a medication treatment and how manageable it feels in practice. Researchers are trying to understand how people respond to a medication treatment in practice and what may need to be adjusted.
ADHDOtherFrom 18 Years to 45 Years
- Countries
- Australia
- Sponsor
- Otsuka Pharmaceutical Development & Commercialization, Inc.
- Condition
- ADHD
CompletedNCT04866030
This study exists to explore whether questionnaires and follow-up reports could improve care and understanding. Researchers are trying to understand what questionnaires and follow-up reports could change in day-to-day care and decision-making.
ADHDOtherFrom 6 Years to 17 Years
- Countries
- Australia
- Sponsor
- Shire
- Condition
- ADHD
TerminatedISRCTN00982930
This public ISRCTN record appears to relate to depression. HopeStage keeps this listing available so people can review the official source, understand the basic study status, and decide what questions to ask before contacting the research team.
DepressionOtherOver 18 Years
- Countries
- Australia
- Sponsor
- Australian National University (Australia)
- Condition
- Depression